{\rtf1\ansi\ansicpg1252\cocoartf2821
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx720\tx1440\tx2160\tx2880\tx3600\tx4320\tx5040\tx5760\tx6480\tx7200\tx7920\tx8640\pardirnatural\partightenfactor0

\f0\fs24 \cf0 \{\
  "FNA Results": \{\
    "Oncocytic follicular neoplasm (Bethesda IV) THYR-1": \{\
      "Diagnostic Procedures": \{\
        "Assess for signs of malignancy": [\
          "Thyroid and neck ultrasound (including central and lateral cervical nodal compartments), if not previously done",\
          "Consider molecular diagnostics",\
          "Screen for personal and/or family history suggestive of inherited cancer risk"\
        ],\
        "Evaluation outcome": \{\
          "Any concerning features": \{\
            "Evidence of locoregional spread (ETE, nodal disease)": \{\
              "Primary Treatment": [\
                "Consider neck CT",\
                "Total thyroidectomy and therapeutic neck dissection",\
                "\uc0\u8594  Postsurgical Evaluation (ONC-2)"\
              ]\
            \},\
            "No evidence of locoregional spread": \{\
              "Primary Treatment": [\
                "Lobectomy or total thyroidectomy (lobectomy may be preferred for smaller tumor)",\
                \{\
                  "Postsurgical pathology result": \{\
                    "Invasive cancer (widely invasive or encapsulated angioinvasive with \uc0\u8805 4 vessels)": \{\
                      "Action": [\
                        "Completion of thyroidectomy",\
                        "\uc0\u8594  Postsurgical Evaluation (ONC-2)"\
                      ]\
                    \},\
                    "Encapsulated angioinvasive with <4 vessels or Minimally invasive oncocytic carcinoma": \{\
                      "Action": [\
                        "Disease monitoring (preferred)",\
                        \{\
                          "If disease monitoring": [\
                            "Consider levothyroxine therapy to keep TSH low or normal",\
                            "\uc0\u8594  Disease Monitoring and Maintenance (ONC-6)"\
                          ]\
                        \}\
                      ]\
                    \},\
                    "Benign": \{\
                      "Action": [\
                        "Disease monitoring",\
                        "\uc0\u8594  Disease Monitoring and Maintenance (ONC-6)"\
                      ]\
                    \}\
                  \}\
                \}\
              ]\
            \}\
          \},\
          "All features reassuring, including molecular genetics": \{\
            "Action": "Observe"\
          \}\
        \}\
      \}\
    \}\
  \}\
\}\
}